Fulcrum Therapeutics, Inc. (FULC)
10.86
-0.01
(-0.09%)
USD |
NASDAQ |
Feb 12, 16:00
10.86
0.00 (0.00%)
Pre-Market: 20:00
Fulcrum Therapeutics Free Cash Flow : -60.41M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agios Pharmaceuticals, Inc. | -414.09M |
| CorMedix, Inc. | 74.42M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.19M |
| Cash from Investing (Quarterly) | 18.61M |
| Cash from Financing (Quarterly) | 0.064M |
| Free Cash Flow Per Share (Quarterly) | -0.2281 |
| Free Cash Flow to Equity (Quarterly) | -13.72M |
| Free Cash Flow to Firm (Quarterly) | -14.28M |
| Free Cash Flow Yield | -9.21% |